434 Phase II Study of Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/− Trastuzumab Followed by Docetaxel in Locally Advanced Breast Cancer (LABC)

Autor:	U.B. Tange, Malgorzata K Tuxen, Dorte Nielsen, S.B. Soendergaard, S. Cold
Rok vydání:	2012
Předmět:	Oncology Cancer Research medicine.medical_specialty Cyclophosphamide business.industry Locally advanced Phases of clinical research medicine.disease Pegylated Liposomal Doxorubicin Breast cancer Docetaxel Trastuzumab Internal medicine Medicine business medicine.drug
Zdroj:	European Journal of Cancer. 48:S173
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(12)70500-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6c44324ebf4ee520a97bc3bedef472a6 https://doi.org/10.1016/s0959-8049(12)70500-2 Zobrazit plný text záznamu Full Text from ScienceDirect